Christopher Lee is a Director at the Milken Institute's Center for Financial Markets, where he also leads the Capital for Innovation program. Lee has previously worked as an entrepreneur, civil servant, private equity investor, and investment banker. He has completed transactions in nearly 30 countries and more than 10 sectors, including technology, financial services, healthcare, real estate, and telecommunications. Lee has led research on innovative finance, and his writing has appeared in Reuters, American Banker, The Hill, MIT Innovations, and other publications. He is a member of the Bretton Woods Committee and serves on the advisory council for CureSearch Catapult, an organization that invests in new treatments for pediatric cancers. He holds degrees in finance and foreign affairs from the University of Virginia.